182
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Oral-based controlled release formulations using poly(acrylic acid) microgels

, , , &
Pages 922-929 | Received 11 Mar 2008, Accepted 17 Dec 2008, Published online: 26 May 2009

References

  • Ahuja A, Khar RK, Chaudhry R. (1998). Evaluation of buccoadhesive metronidazole tablets: Microbiological response. Pharmazie, 53(4):264–7.
  • Ali J, Khar RK, Ahuja A. (1998). Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions. Pharmazie, 53(5):329–34.
  • Ceschel GC, Maffei P, Lombardi Biogia S, Ronchi C. (2001). Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv, 8(3):161–71.
  • Eouani C, Piccerelle P, Prinderre P, Bourret E, Joachim J. (2001). In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur J Pharm Biopharm, 52(1):45–55.
  • Guo JH. (1994). Investigating the surface properties and bioadhesion of buccal patches. J Pharm Pharmacol, 46(8):647–50.
  • Li C, Bhatt PP, Johnston TP. (1997). Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm Dev Technol, 2(3):265–74.
  • Pedrazzi V, Lara EH, Dal Ciampo JO, Panzeri H. (2001). Tensile bond strength of a polymeric intra-buccal bioadhesive: The mucin role. Boll Chim Farm, 140(6):471–4.
  • Peh KK, Wong CF. (1999). Polymeric films as vehicle for buccal delivery: Swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci, 2(2):53–61.
  • Shin SC, Kim JY. (2000). Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur J Pharm Biopharm, 50(2):217–20.
  • Callens C, Adriaens E, Dierckens K, Remon JP. (2001). Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol 974 P on rabbit nasal mucosa and slug mucosa. J Control Release, 76(1–2):81–91.
  • Callens C, Remon JP. (2000). Evaluation of starch-maltodextrin-Carbopol(R) 974 P mixtures for the nasal delivery of insulin in rabbits. J Control Release, 66(2–3):215–20.
  • Ugwoke MI, Agu RU, Jorissen M, Augustijns P, Sciot R, Verbeke N, (2000). Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: Effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur J Pharm Sci, 9(4):387–96.
  • El-Shafy MA, Kellaway IW, Taylor G, Dickinson PA. (2000). Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits. J Drug Target, 7(5):355–61.
  • Witschi C, Mrsny RJ. (1999). In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm Res, 16(3):382–90.
  • Ceulemans J, Vermeire A, Adriaens E, Remon JP, Ludwig A. (2001). Evaluation of a mucoadhesive tablet for ocular use. J Control Release, 77(3):333–44.
  • Davies NM, Farr SJ, Hadgraft J, Kellaway IW. (1992). Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles. Pharm Res, 9(9):1137–44.
  • Durrani AM, Farr SJ, Kellaway IW. (1995). Precorneal clearance of mucoadhesive microspheres from the rabbit eye. J Pharm Pharmacol, 47(7):581–4.
  • Dash AK, Gong Z, Miller DW, Huai-Yan H, Laforet J. (1999). Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. Int J Pharm, 190(1):21–34.
  • Betageri GV, Deshmukh DV, Gupta RB. (2001). Oral sustained-release bioadhesive tablet formulation of didanosine. Drug Dev Ind Pharm, 27(2):129–36.
  • Cuna M, Alonso MJ, Torres D. (2001). Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxycillin-resin complexes for drug delivery to the gastric mucosa. Eur J Pharm Biopharm, 51(3):199–205.
  • Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. (1995). In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative. Pharm Res, 12(3):397–405.
  • Ilan E, Amselem S, Weisspapir M, Schwarz J, Yogev A, Zawoznik E, (1996). Improved oral delivery of desmopressin via a novel vehicle: Mucoadhesive submicron emulsion. Pharm Res, 13(7):1083–7.
  • Aboofazeli R, Mortazavi SA. (2003). An investigation into the effect of carbopols on the release of propranolol HCl from tablet matrices. Iran. J Pharm Res, 2:23–7.
  • Aboofazeli R, Mortazavi SA. (2003). An investigation into the optimization of release profile of lithium carbonate from matrix-type tablets containing Carbopols, Pemulen and Eudragits. Iran J Pharm Res, 2:33–8.
  • Esposito E, Bortolotti F, Nastruzzi C, Menegatti E, Cortesi R. (2003). Diffusion of preservatives from topical dosage forms: A comparative study. J Cosmet Sci, 54(3):239–50.
  • Simovic S, Tamburic S, Milic-Askrabi J, Rajic D. (1999). An investigation into interactions between polyacrylic polymers and a non-ionic surfactant: An emulsion preformulation study. Int J Pharm, 184(2):207–17.
  • Anlar S, Capan Y, Hincal AA. (1993). Physico-chemical and bioadhesive properties of polyacrylic acid polymers. Pharmazie, 48(4):285–7.
  • Bramer T, Paulsson M, Edwards K, Edsman K. (2003). Catanionic drug–surfactant mixtures: Phase behavior and sustained release from gels. Pharm Res, 20:1661–7.
  • Paulsson M, Edsman K. (2001). Controlled drug release from gels using surfactant aggregates. I. Effect of lipophilic interactions for a series of uncharged substances. J Pharm Sci, 90:1216–26.
  • Paulsson M, Edsman K. (2001). Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants. Pharm Res, 18:1586–92.
  • Paulsson M, Edsman K. (2002). Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers. J Colloid Interface Sci, 248:194–200.
  • Genc L, Bilac H, Guler E. (1999). Studies on controlled release dimenhydrinate from matrix tablet formulations. Pharm Acta Helv, 74:43–9.
  • Juang R-H, Storey D. (2003). Correlation of characteristics of gel extrusion module (GEM) tablet formulation and drug dissolution rate. J Control Release, 89:375–85.
  • National Library of Medicine. (2005). http://pubchem.ncbi.nlm.nih.gov [July 17, 2005].
  • Kallinteri P, Antimisiaris SG. (2001). Solubility of drugs in the presence of gelatin: Effect of drug lipophilicity and degree of ionization. Int J Pharm, 221:219–26.
  • RXlist. (2005). http://www.rxlist.com/cgi/generic3/midodrine.htm. [July 15, 2005].
  • The Lubrizol Corporation Data Sheets. (2009). http://www.personalcare.noveon.com/literature/spec.asp. [December 9, 2009].
  • van Drooge DJ, Hinrichs WLJ, Frijlink HW. (2004). Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J Control Release, 97:441–52.
  • Ritger PL, Peppas NA. (1987). A simple equation for description of solute release I. Fickian and Non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release, 5:23–36.
  • Efentakis M, Pagoni I, Vlachou M, Avgoustakis K. (2007). Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility. Int J Pharm, 339:66–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.